Safety Study Comparing Phenylephrine HCL Extended Release Tablets 30 mg and Placebo (Study CL2007-07)(P07529)(COMPLETED)
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
Randomized, placebo-controlled double-blind, crossover design study; 116 subjects randomized
on Day 1 to obtain 98 completed subjects. Study will be composed of a 7-day period of therapy
with randomized active or placebo treatment with a subsequent 6-8 day washout period,
followed by a second 7-day period of double-blind therapy with the other agent. Ambulatory
blood pressure measurement will be performed beginning on Day 7 of each treatment period
following administration of the study drug.